US HB1857 | 2021-2022 | 117th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on March 11 2021 - 25% progression, died in committee
Action: 2021-03-12 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 11 2021 - 25% progression, died in committee
Action: 2021-03-12 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to clarify the meaning of a new chemical entity.
Title
Protecting Access to Safe and Effective Medicines Act of 2021
Sponsors
Rep. Kurt Schrader [D-OR] | Rep. Brett Guthrie [R-KY] |
History
Date | Chamber | Action |
---|---|---|
2021-03-12 | House | Referred to the Subcommittee on Health. |
2021-03-11 | House | Referred to the House Committee on Energy and Commerce. |
2021-03-11 | House | Introduced in House |
Same As/Similar To
HB19 (Related) 2021-10-19 - Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/117th-congress/house-bill/1857/all-info |
Text | https://www.congress.gov/117/bills/hr1857/BILLS-117hr1857ih.pdf |